I’m pleased to announce that Angiex has dosed the first patient in our Phase 1 clinical trial of AGX101, Angiex’s lead drug.
As some of you know, 9 years ago Shou-Ching and I suspended our blog and health retreat to create Angiex. It’s been a busy and exciting nine years, and I’m looking forward to telling you about the special biology Shou-Ching discovered and the drug we’ve made in the weeks ahead.
But for today, I’m happy to simply savor the accomplishment of finally having the opportunity to test what we’ve made in clinical cancer patients. This is the fruit of 20 years of biology research and 12 years of drug development. Please keep an eye out for upcoming posts, and say a prayer for the success of Angiex and the cancer patients we are treating.
Some links:
- Angex web site: https://angiex.com
- Press release: https://www.globenewswire.com/news-release/2024/08/07/2926298/0/en/Angiex-Announces-First-Patient-Dosed-in-Phase-1-Clinical-Trial-of-AGX101-a-novel-TM4SF1-Directed-Antibody-Drug-Conjugate-for-the-Treatment-of-Solid-Tumors.html
- My LinkedIn: https://www.linkedin.com/posts/pauljaminet_im-very-happy-to-announce-that-angiexs-activity-7227092290014457860-5Of-/
- My Twitter: https://x.com/pauljaminet/status/1821333109587025938
via this link:
Outstanding
What wonderful and exciting news, Paul! Congratulations to both of you. Please keep us updated. I’m sending my heartfelt prayers and intent for a positive outcome
Congratulations!
Dear Paul,
I would like to thank you and your wife for your fantastic and important work. You have helped so many people through your work and research. You are the kind of scientist this world needs. May God protect you and your family and support you on your further journey. I pray for you and your company.
Best regards
Marvin
Congratulations!
Awesome to hear! All the best.
Wow! This is wonderful news! Prayers for great success with clinical trials. Congratulations!
Fantastic news Paul! Congratulations!
So happy for you both!
Congratulations both of you!